Selected Grants
exPDite-2: A Phase 3 Study to Assess the Efficacy and Safety of Midbrain Dopaminergic Neuronal Cell Therapy (Bemdaneprocel) for Participants With Parkinson's Disease
Clinical TrialPrincipal Investigator · Awarded by BlueRock Therapeutics LP · 2025 - 2032An open-label clinical trial investigating the long-term safety of buntanetap in treating participants with Parkinson's disease
Clinical TrialPrincipal Investigator · Awarded by DCRI-Duke-Site · 2026 - 2029An Integrated Biomarker Approach to Personalized, Adaptive Deep Brain Stimulation in Parkinson Disease
ResearchCo Investigator · Awarded by National Institute of Neurological Disorders and Stroke · 2023 - 2027Characterizing Evoked Potentials of Deep Brain Stimulation for Parkinson's Disease
FellowshipCo-Mentor · Awarded by National Institute of Neurological Disorders and Stroke · 2023 - 2026Deep Brain Stimulation Evoked Potentials (SRA2)
ResearchCo Investigator · Awarded by Boston Scientific Corporation · 2021 - 2026Visualization of the STN and GPi for DBS Surgery in Patients with Parkinson's Disease: VISION Stud
ResearchPrincipal Investigator · Awarded by Surgical Information Sciences, Inc · 2023 - 2025Adaptive DBS Algorithm for Personalized Therapy - Parkinson's Disease (ADAPT-PD)
Clinical TrialPrincipal Investigator · Awarded by Medtronic, Inc. · 2021 - 2025Telemedicine agreement for TOPAZ Clinical Trial
ResearchPhysician · Awarded by Parkinson Foundation · 2020 - 2025A Prospective, Randomized, Cross-Over Home-Use Study of TOPS® DBS for the Treatment of Parkinson's disease Phase n/a
Clinical TrialPrincipal Investigator · Awarded by Deep Brain Innovations · 2019 - 2023Scalar Closed-Loop STN/GPi DBS Based on Evoked and Spontaneous Potentials
ResearchInvestigator · Awarded by National Institutes of Health · 2017 - 2023External Relationships
- Boston Scientific Corporation
- Medtronic
- dannce.ai, inc.
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.